ARAKODA (nda210607)- (EQ 100MG BASE)

Generic Name	TAFENOQUINE SUCCINATE	Innovator	60 DEGREES PHARMS
Dosage	EQ 100MG BASE
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2035-Dec-02	NCE Excl Expiry	2023-Jul-20
ODE Expiry	None	NP Expiry	2021-Aug-08
GAIN Expiry	None	Drug Complexity	No
Indication	ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 100MG BASE	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of ARAKODA